DocDollars

Glaukos Corporation

CA · United States · Reporting entity ID 100000000102

Total reported 2019–2025
$60.6M
#147 of 2,960 reporting companies — 0.1% of all reported industry payments
$19.9M in general payments across 58,175 records, plus $39.4M in research funding across 15,135 records.

How it breaks down

General payments $19,854,423
Research funding $39,382,759
Ownership & investment $1,323,445

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Glaukos Corporation reported $60.6M to US doctors and teaching hospitals from 2019 to 2025, ranking #147 of 2,960 reporting companies. 65% of that was research funding and 35% general payments such as consulting, speaking, food and travel. 58,175 general payment records and 15,135 research records were filed.

Common questions about Glaukos Corporation

How much has Glaukos Corporation paid US doctors?

Glaukos Corporation reported $60,560,626 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $19,854,423 in general payments, $39,382,759 in research funding and $1,323,445 in ownership and investment interests.

How does Glaukos Corporation rank among drug and device companies?

It ranks #147 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Glaukos Corporation mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.